Navigation Links
Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data
Date:1/29/2008

TORONTO, Jan. 29 /PRNewswire/ - Viventia Biotech Inc., a privately held biopharmaceutical company advancing a portfolio of novel antibody therapeutics focused on cancer, announced today it intends to explore strategic alternatives to further advance and realize value from its pipeline of therapeutic antibodies, its antibody discovery platform and its antibody manufacturing capabilities. The Company will consider potential strategic opportunities including, but not limited to, the sale or merger of the Company with another entity, and has retained HSBC to act as advisors in this process.

The Company also provided an update on the clinical development programs for Proxinium(TM) (Phase 3), Vicinium(TM) (Phase 2) and VB6-845 (Phase 1). Proxinium(TM) is undergoing a global pivotal Phase 3 trial (the 'TARGET' trial) in approximately 300 patients with advanced head and neck cancer. Viventia recently completed an interim efficacy assessment on the study's primary endpoint of median survival. These preliminary results demonstrated a clear survival advantage in the Proxinium(TM) arm.

"We have successfully advanced three antibody programs into clinical trials, and are about twelve months from expected final efficacy data for our pivotal Phase 3 TARGET trial of Proxinium(TM). We believe that our recently performed interim efficacy analysis of survival data from TARGET strongly supports the future prospects for this drug. In addition to our clinical programs, we have generated a broad pipeline from our antibody discovery platform, which has yielded a number of compelling novel targets, including several that have expression profiles consistent with cancer stem cells, an exciting new area of cancer research," said Dr. Nick Glover, President and CEO of Viventia Biotech. "We believe it is important to explore all options to ensure adequate resources are available for the advancement of our products through to commercialization and to further recognize the value
'/>"/>

SOURCE Viventia Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
3. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
4. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
5. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
6. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
7. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
8. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
9. Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
10. Favrille CEO to Present at NewsMakers in the Biotech Industry Investment Conference
11. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009).... - A new generation of ultrasmall transistors and...s called semiconducting nanowires are closer to re... Purdue University and the University of Californi... how to create nanowires with layers of different ...evel, which is a critical requirement for making e...
(Date:11/25/2009)... Nov. 25 Biotech firm Replikins Lt...a from the 1918 pandemic through the prediction, o..., today issued its latest biochemical analysis of ...f the H1N1 ("Swine Flu") virus has dropped from it...t outbreak in the spring of 2009 to resting non-ep...
(Date:11/25/2009)..., ,, BOCA RATON, Fla., Nov. 25 /PRNewswire...year. Not so for BodyLogicMD. The nation,s larges... specializing exclusively in medically supervised ... physicians in its network since November 2008...to add more physician-owned centers, including one...
(Date:11/25/2009)...IJING, Nov. 25 /PRNewswire-Asia/ -- Sinovac Biotec... vaccines, announced today that it executed,a join...ian) Vaccine,Technology Co., Ltd. (Sinovac Dalian)...rcialize human-use vaccines. Sinovac will contribu...commercializing world-class vaccines; the,other pa...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3
... a Grow Wisconsin forum in Eau Claire Thursday, Go...Falls will receive $250,000 in Technology Zone tax...ate 214 jobs, retain 751 jobs at its Chippewa Fall...uipment. , ,TTM Technologies produces complex prin... facilities, with the largest, its Chippewa Falls ...
...erv, Inc., an ATM and point-of-sale (POS) process...unds transfer network saw its volume increase more...,"Our overall growth rate of 57% was tremendous an... growing EFT networks," said Kevin Gregoire, Senio...rv EFT/CNS. "In 2003, we added more than 22,000 AT...
...chnology executives, investors, and media is a lea...bound. Maybe Homestead CEO Justin Kitch captured i...the mo, was back in the good ol, Internet." , ,Kit...es who talked to or emailed me during and after th...e any we,ve felt in the past 36 months. There is e...
Other Biology Technology:The Tech Market is Looking Up 2The Tech Market is Looking Up 3The Tech Market is Looking Up 4
(Date:11/30/2009)...yth Institute, the University of Connecticut Healt...sed state-of-the-art technology to elucidate the m...acterium which causes syphilis. The previously unk... shown in three dimensions. This provides the firs...y unknown features, which may help fight the sprea...
(Date:11/30/2009)...LSU Health Sciences Center New Orleans School of P...itute of Child Health and Human Development (NICHD...men,s Hospital, and Harvard Medical School, have f...servings of sugar- sweetened cola a week prior to ...k of developing diabetes during pregnancy. Liwei C...
(Date:11/30/2009)...bal Conference on Systems & Enterprises (GCSE), to...cuses on the convergence of complex large-scale sy...ciety. , The goal of the conference is to bu...ed complex systems, examined by domain, each succe...nfrastructure Systems, including Intelligent/Smart...
Breaking Biology News(10 mins):Scientists gain new understanding of disease-causing bacteria 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 3First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2Water For People Selected for 241 56 Million Project in Africa 58560 1Water For People Selected for 241 56 Million Project in Africa 58560 2Water For People Selected for 241 56 Million Project in Africa 58560 3Water For People Selected for 241 56 Million Project in Africa 58560 4National Hispanic Council on Aging Urges Healthcare Reform and Geriatrics Training for Health Professionals as Older Americans Reach 20 25 of Populati 58557 1National Hispanic Council on Aging Urges Healthcare Reform and Geriatrics Training for Health Professionals as Older Americans Reach 20 25 of Populati 58557 2National Hispanic Council on Aging Urges Healthcare Reform and Geriatrics Training for Health Professionals as Older Americans Reach 20 25 of Populati 58557 3Polaroid 28R 29 and The Breast Cancer Research Foundation 28R 29 Print Pink 58554 1Polaroid 28R 29 and The Breast Cancer Research Foundation 28R 29 Print Pink 58554 2
...kes and seas on Saturn,s moon Titan taken by the C...ew radar image comprised from seven Titan fly-bys ...itted with giant lakes and seas, at least one of t...est freshwater lake on Earth. Approximately 60% of...een mapped by Cassini,s radar instrument. About 14...
...nnsylvania have discovered that the nuclei of huma...ather than hard, making it easier for stem cells t...shapes, but ultimately to put human genes in the c...sion. ,Researchers pulled cell nuclei into microsc...sualized the shear of the DNA and associated prote...
...ut how can we find out about the future dangers it...e Earths climate for several hundred thousand year...chs that can be taken to the lab for analysis. Inc... Arctic and Antarctic regions, and a European Scie...ring it. , Professor Thomas Stocker of the Univer...
Other Biology News:Cassini's new view of land of lakes and seas 2Stem cell nuclei are soft 'hard drives,' Penn study finds 2European lead in reading past climates from ice cores 2European lead in reading past climates from ice cores 3
...P-165 is an 18 amino acid synthetic peptide whose ... The sequence of this peptide is (amino to carbox... - E - A - I - D - K - K - I - K - Q - D - C(39). ...control experiments with the polyclonal antibody t...
...stom peptide microarrays designed for quantitative...erum samples and built on the flexible and powerfu...ds of customer specified sequences can be synthesi... with custom sequence design. These microarrays ar...
...utralizing synthetic peptide for OPA1-01009, OPEP-...tic peptide whose sequence is from human DNA fragm...de is (amino to carboxy terminus): Q(3) - K - P - ...18). This peptide may be used for neutralization...
...emicon Select Tissue Arrays are intended for labor...ere fixed in neutral buffered formalin and embedde...s was performed by certified pathologists. Tissue... relocated into a new recipient paraffin block, in...
Biology Products: